Heterodimeric interaction between retinoid X receptor α and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 3977-3986

  Wiebel, Franziska F ^a   Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID; RETINOID; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DIMERIZATION; DNA BINDING; ELECTROPHORETIC MOBILITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 0031011661     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.7.3977     Document Type: Article

References (62)

1. Allan, G. F., X. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M. J. Tsai, and B. W. O'Malley. 1992. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513-19520.
2. Apfel, R., D. Benbrook, E. Lernhardt, M. A. Ortiz, G. Salbert, and M. Pfahl. 1994. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 14:7025-7035.
3. Baniahmad, A., X. Leng, T. P. Burris, S. Y. Tsai, M.-J. Tsai, and B. W. O. Malley. 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76-86.
4. Barettino, D., M. M. Vivanco Ruiz, and H. G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:3039-3049.
5. Berger, J., P. Bailey, C. Biswas, C. A. Cullinan, T. W. Doebber, N. S. Haves, R. Saperstein, R. G. Smith, and M. D. Leibowitz. 1996. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137:4189-4195.
6. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (London) 375:377-382.
7. Carey, M., H. Kakidani, J. Leatherwood, F. Mostashari, and M. Ptashne. 1989. An amino-terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209:423-432.
8. Casanova, J., E. Helmer, S. Selmi-Ruhy, J. S. Qi, M. Au-Fliegner, V. DesaiYajnik, N. Koudinova, F. Yarm, B. M. Raaka, and H. H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:5756-5765.
9. Cavaillès, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation hy the estrogen receptor. EMBO J. 14:3741-3751.
10. Chakravarti, D., V. J. Lamorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature (London) 383:99-103.
11. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (London) 377:454-457.
12. Chen, J. D., K. Umesono, and R. M. Evans. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-7571.
13. Cheskis, B., and L. P. Freedman. 1996. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmnn resonance. Biochemistry 35:3309-3318.
14. Claret, F. X., T. Antakly, M. Karin, and F. Saatcioglu. 1996. A shift in the ligand responsivencss of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha. Mol. Cell. Biol. 16:219-227.
15. Cooney, A. J., X. Leng, S. Y. Tsai, B. W. O'Malley, and M. J. Tsai. 1993. Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. J. Biol. Chem. 268:4152-4160.
16. Danielian, P. S., R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025-1033.
17. Dowell, P., V. J. Peterson, T. M. Zabriskie, and M. Leid. 1997. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272:2013-2020.
18. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
19. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
20. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
21. Gearing, K. L., M. Göttlicher, M. Teboul, E. Widmark, and J.-Å. Gustafsson. 1993. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 90:1440-1444.
22. Giguère, V., L. D. McBroom, and G. Flock. 1995. Determinants of target gene specificity for ROR alpha 1: monomeric DNA binding by an orphan nuclear receptor. Mol. Cell. Biol. 15:2517-2526.
23. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrine Rev. 15:391-407.
24. Gronemeyer, H., and V. Landet. 1995. Transcription factors 3: nuclear receptors. Prot. Profile 2:1173-1308.
25. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
26. Hörlein, A. J., A. M. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Söderström, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (London) 377:397-404.
27. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature (London) 383:728-731.
28. Judelson, C., and M. L. Privalsky. 1996. DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants. J. Biol. Chem. 271:10800-10805.
29. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
30. Keidel, S., P. LeMotte, and C. Apfel. 1994. Different agonist-and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol. Cell. Biol. 14:287-298.
31. Kliewer, S. A., K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (London) 358:771-774.
32. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (London) 371:528-531.
33. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (London) 377:451-454.
34. Kurokawa, R., V. C. Yu, A. Näär, S. Kyakumoto, Z. Han, S. Silverman, M. G. Rosenfeld, and C. K. Glass. 1993. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:1423-1435.
35. La Vista-Picard, N., P. D. Hobbs, M. Pfahl, M. I. Dawson, and M. Pfahl. 1996. The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal. Mol. Cell. Biol. 16:4137-4146.
36. Lala, D. S., R. Mukherjee, I. G. Schulman, S. S. Canan Koch, L. J. Dardashti, A. M. Nadzan, G. E. Croston, R. M. Evans, and R. A. Heyman. 1996. Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature (London) 383:4511-453.
37. Laudet, V., C. Hanni, J. Coll, F. Catzeflis, and D. Stehelin. 1992. Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1003-1013.
38. Leblanc, B. P., and H. G. Stunnenberg. 1995. 9-cis retinoic acid signaling: changing partners causes some excitement. Genes Dev. 9:1811-1816.
39. LeDouarin, B., C. Zechel, J. M. Garnier, Y. Lutz, L. Tora, P. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020-2033.
40. Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature (London) 374:91-94.
41. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J.-L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272:3137-3140.
42. Lemotte, P. K., S. Keidel, and C. M. Apfel. 1996. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236:328-333.
43. Leng, X., J. Blanco, S. Y. Tsai, K. Ozato, B. W. O'Malley, and M. J. Tsai. 1995. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol. 15:255-263.
44. Leng, X., S. Y. Tsai, B. W. O'Malley, and M. J. Tsai. 1993. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J. Steroid Biochem. Mol. Biol. 46:643-661.
45. Lu, X. P., N. L. Eberhardt, and M. Pfahl. 1993. DNA bending by retinoid X receptor-containing retinoid and thyroid hormone receptor complexes. Mol Cell. Biol. 13:6509-6519.
46. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR hetcrodimers and orphan receptors. Cell 83:841-850.
47. Mangelsdorf, D. J., C. Tnummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
48. Oñate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor supeifamily. Science 270:1354-1357.
49. Parker, M. G., and R. White. 1996. Nuclear receptors spring into action. Nat. Struct. Biol. 3:113-115.
50. Perlntann, T., K. Umesono, P. N. Rangarajan, B. M. Forman, and R. M. Evans. 1996. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol. Endocrinol. 10: 958-966.
51. Rastinejad, F., T. Perlmann, R. M. Evans, and P. B. Sigler. 1995. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (London) 375:203-211.
52. Renaud, J. P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (London) 378:681-689.
53. Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807-3813.
54. Seol, W. G., H. S. Choi, and D. D. Moore. 1995. Isolation of proteins that interact specifically with the retinoid x receptor - two novel orphan receptors. Mol. Endocrinol. 9:72-85.
55. Shinar, D. M., N. Endo, S. J. Rutledge, R. Vogel, G. A. Rodan, and A. Schmidt. 1994. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene 147:273-276.
56. Song, C., J. M. Kokontis, R. A. Hiipakka, and S. Liao. 1994. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc. Natl. Acad. Sci. USA 91:10809-10813.
57. Teboul, M., E. Enmark, Q. Li, A. C. Wikström, M. Pelto-Huikko, and J.-Å. Gustafsson. 1995. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc. Natl. Acad. Sci. USA 92:2096-2100.
58. Toney, J. H., L. Wu, A. E. Summerfield, G. Sanyal, B. M. Forman. J. Zhu, and H. H. Samuels. 1993. Conformational changes in chicken thyroid hormone receptor alpha 1 induced by binding to ligand or to DNA. Biochemistry 32:2-6.
59. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature (London) 378:690-697.
60. Willy, P. J., K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and D. J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033-1045.
61. Yao, T. P., B. M. Forman, Z. Jiang, L. Cherbas, J. D. Chen, M. McKeown P. Cherbas, and R. M. Evans. 1993. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature (London) 366:476-479.
62. Zhang, X. K., J. Lehmann, B. Hoffmann, M. I. Dawson, J. Cameron, G. Graupner, T. Hermann, P. Tran, and M. Pfahl. 1992. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (London) 358:587-591.